Department of Anaesthesiology, Zhongshan Hospital, Fudan University, No 180 Fenglin Road, Xuhui District, Shanghai, 20032, China.
Eur J Med Res. 2023 Jan 24;28(1):45. doi: 10.1186/s40001-023-00990-2.
Acute kidney injury (AKI) is a common and serious complication of cardiac surgery and is associated with increased mortality and morbidity, accompanied by a substantial economic burden. The pathogenesis of cardiac surgery-associated acute kidney injury (CSA-AKI) is multifactorial and complex, with a variety of pathophysiological theories. In addition to the existing diagnostic criteria, the exploration and validation of biomarkers is the focus of research in the field of CSA-AKI diagnosis. Prevention remains the key to the management of CSA-AKI, and common strategies include maintenance of renal perfusion, individualized blood pressure targets, balanced fluid management, goal-directed oxygen delivery, and avoidance of nephrotoxins. This article reviews the pathogenesis, definition and diagnosis, and pharmacological and nonpharmacological prevention strategies of AKI in cardiac surgical patients.
急性肾损伤(AKI)是心脏手术中常见且严重的并发症,与死亡率和发病率增加相关,并伴随着巨大的经济负担。心脏手术后急性肾损伤(CSA-AKI)的发病机制是多因素和复杂的,有多种病理生理学理论。除了现有的诊断标准外,生物标志物的探索和验证是 CSA-AKI 诊断领域的研究重点。预防仍然是 CSA-AKI 管理的关键,常见的策略包括维持肾灌注、个体化血压目标、平衡液体管理、目标导向的氧输送和避免肾毒性药物。本文综述了心脏外科患者 AKI 的发病机制、定义和诊断,以及药物和非药物预防策略。